KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 99 filers reported holding KEROS THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,480,264 | -28.8% | 77,800 | -10.3% | 0.02% | -36.7% |
| Q2 2023 | $3,484,690 | +44.3% | 86,727 | +53.4% | 0.03% | +30.4% |
| Q1 2023 | $2,414,471 | +24.8% | 56,545 | +40.3% | 0.02% | +43.8% |
| Q4 2022 | $1,935,206 | +96.7% | 40,300 | +122.7% | 0.02% | +77.8% |
| Q1 2022 | $984,000 | +4.8% | 18,097 | +12.8% | 0.01% | 0.0% |
| Q4 2021 | $939,000 | -10.5% | 16,044 | -5.9% | 0.01% | -30.8% |
| Q1 2021 | $1,049,000 | – | 17,046 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 407,633 | $12,995,340 | 5.15% |
| Opaleye Management Inc. | 360,400 | $11,489,552 | 3.74% |
| Parkman Healthcare Partners LLC | 298,475 | $9,515,383 | 1.74% |
| BRAIDWELL LP | 1,357,309 | $43,271,011 | 1.37% |
| First Light Asset Management, LLC | 421,438 | $13,435,443 | 1.28% |
| Orbimed Advisors | 1,514,734 | $48,289,720 | 1.03% |
| Yiheng Capital Management, L.P. | 554,151 | $17,666,334 | 0.90% |
| Nantahala Capital Management | 328,781 | $10,481,538 | 0.90% |
| DAFNA Capital Management LLC | 65,961 | $2,102,837 | 0.65% |
| EDBI Pte Ltd | 10,105 | $322,147 | 0.35% |